Zheng C,Wang J,Chen T .2019 .Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population. Sci Rep, 9 : 2694.
Fernandez FB,Sarafidis P,Kanbay M .2020 .SGLT2 inhibitors for nondiabetic kidney disease: drugs to treat CKD that also improve glycaemia. Clin Kidney J, 13(5) : 728-33.
Ameen ,Kashif MA .2016 .To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease. Pak J Med Sci, 32(3) : 613-16.
Lin T,Hung LY,Chen Y .2019 .Effects of febuxostat on renal function in patients with chronic kidney disease. A systemic review nad metaanalysis. Medicine (Baltimore), 98(29) : e16311.
Zeng XX,Tang Y,Hu K .2018 .Efficacy of febuxostat inhyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials. A PRISMA-compliant article. Medicine (Baltimore), 97(13) : e0161.
Peng Y,Tain Y,Lee C .2020 .Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease. Sci Rep, 10 : 107-34.
Becker MA,Kisicki J,Khosravan R .2004 .a noval non-purine, selective inhibitor of xanthine oxidose, is safe and decreases serum urate in healthy volunteers. Nucleosides nucleotides nucleic acids, 23 : 1111-16.
Omori H,Kawada N,Inoue K. .2012 .Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin Exp Nephrol, 16 : 549-56.
.2011 .. Am J Med, 124 : 155-63.
Sakai Y,Otsuka T,Ohno D .2014 .Febuxostat for treating allopurinolresistant hyperuricemia in patients with chronic kidney disease. Ren Fail, 36 : 225-31.
Tsuruta Y,Mochizuki T,Moriyama T .2014 .Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol, 33 : 1643-48.
Perez-Ruiz Borghi C,F Borghi C .2016 .Urate lowering therapies in the treatment of gout: A systematic review and meta-analysis. Eur Rev Med Pharmacol Sci, 20 : 983-92.